Proton magnetic resonance spectroscopic imaging in pediatric major depression

被引:78
|
作者
Farchione, TR
Moore, GJ
Rosenberg, DR
机构
[1] Wayne State Univ, Sch Med, Univ Hlth Ctr, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA
关键词
depression; pediatric; child; proton magnetic resonance spectroscopy; dorsolateral prefrontal cortex; brain;
D O I
10.1016/S0006-3223(02)01340-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Neurobiologic abnormalities in dorsolateral prefrontal cortex (DLPFC) are believed to be involved in the pathophysiology of major depressive disorder (MDD). Although MDD commonly emerges during childhood and adolescence, to out-knowledge, no prior study has examined the DLPFC in pediatric patients with MDD. Methods: In this study, choline compounds (Cho), N-acetylaspartate (NAA), and creatine/phosphocreatine (Cr) were measured in left and right DLPFC using a multislice proton magnetic resonance spectroscopic imaging sequence with validated phantom replacement methodology in 11 treatment-naive MDD patients, 10-16 years of age, and 11 case-matched healthy control subjects. Results: A significant increase in Cho was observed in left but not right DLPFC in MDD patients versus control subjects (32.5% higher). No significant differences in NAA or Cr were observed between case-control pairs. Conclusions: These results provide new evidence of localized functional neurochemical marker alterationsi in left DLPFC in pediatric MDD. Our results must be considered preliminary, however, given the small sample size.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 50 条
  • [11] Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases
    Schuff, N
    Vermathen, P
    Maudsley, AA
    Weiner, MW
    CURRENT SCIENCE, 1999, 76 (06): : 800 - 807
  • [13] Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration
    Tedeschi, G
    Bertolino, A
    Massaquoi, SG
    Campbell, G
    Patronas, NJ
    Bonavita, S
    Barnett, AS
    Alger, JR
    Hallett, M
    ANNALS OF NEUROLOGY, 1996, 39 (01) : 71 - 78
  • [14] Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia
    Bertolino A.
    Callicott J.H.
    Nawroz S.
    Mattay V.S.
    Duyn J.H.
    Tedeschi G.
    Frank J.A.
    Weinberger D.R.
    Neuropsychopharmacology, 1998, 18 (1) : 1 - 9
  • [15] PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING IN NEONATAL STROKE
    GROENENDAAL, F
    VANDERGROND, J
    WITKAMP, TD
    DEVRIES, LS
    NEUROPEDIATRICS, 1995, 26 (05) : 243 - 248
  • [16] Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy
    Stanley, JA
    Cendes, F
    Dubeau, F
    Andermann, F
    Arnold, DL
    EPILEPSIA, 1998, 39 (03) : 267 - 273
  • [17] Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis
    Gruber, S
    Stadlbauer, A
    Mlynarik, V
    Gatterbauer, B
    Roessler, K
    Moser, E
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2005, 16 (01) : 101 - +
  • [18] Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia
    Bertolino, A
    Callicott, JH
    Nawroz, S
    Mattay, VS
    Duyn, JH
    Tedeschi, G
    Frank, JA
    Weinberger, DR
    NEUROPSYCHOPHARMACOLOGY, 1998, 18 (01) : 1 - 9
  • [19] Proton magnetic resonance spectroscopic imaging of the brain in childhood autism
    Levitt, JG
    O'Neill, J
    Blanton, RE
    Smalley, S
    Fadale, D
    McCracken, JT
    Guthrie, D
    Toga, AW
    Alger, JR
    BIOLOGICAL PSYCHIATRY, 2003, 54 (12) : 1355 - 1366
  • [20] Proton magnetic resonance spectroscopic imaging in first episode schizophrenia
    Bertolino, A
    Sciota, D
    Brudaglio, F
    Scarabino, T
    Callicott, JH
    van der Veen, JW
    Barnett, AS
    Duyn, JH
    Weinberger, DR
    Nardini, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 155S - 155S